-       Report 
- March 2021
-  137 Pages 
- Global 
   From       €4383EUR$4,900USD£3,855GBP 
          -       Report 
- February 2024
-  111 Pages 
- Global 
   From       €3500EUR$4,192USD£3,186GBP 
          -       Report 
- July 2023
-  108 Pages 
- Global 
   From       €3500EUR$4,192USD£3,186GBP 
          -       Report 
- July 2023
-  113 Pages 
- Global 
   From       €3500EUR$4,192USD£3,186GBP 
          -       Report 
- November 2021
-  802 Pages 
- Global 
   From       €4472EUR$5,000USD£3,934GBP 
           -       Report 
- November 2021
-  1184 Pages 
- Global 
   From       €5367EUR$6,000USD£4,721GBP 
                 DNA vaccines are a type of genomics-based vaccine that uses genetic material from a virus or bacteria to stimulate an immune response. They are created by introducing a gene that codes for a specific antigen into a plasmid, which is then inserted into a host cell. The host cell then produces the antigen, which is then used to stimulate an immune response. DNA vaccines are considered to be safer than traditional vaccines, as they do not contain any live virus or bacteria. Additionally, they can be    produced more quickly and cheaply than traditional vaccines.
DNA vaccines have been used to treat a variety of diseases, including influenza, malaria, and HIV. They have also been used to develop vaccines for cancer and other diseases. Recently, DNA vaccines have been used to develop vaccines for the prevention of infectious diseases, such as Zika virus and Ebola.
Companies in the DNA Vaccines market include Moderna, Inovio Pharmaceuticals, Novavax, and Transgene. Show Less   Read more